Efficacy,tolerability and side effects of 35% Trichloroacetic acid and 50% Glycolic acid peel in Acanthosis nigricans.

Efficacy,Tolerability And Side effects of 35% Trichloroacetic acid and 50% Glycolic acid peel in Acanthosis nigricans-Single Blinded Randamonized Control Trial

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017285

Enrollment

Registered

2019-01-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L83- Acanthosis nigricans

Interventions

Intervention1: 35% Trichloroacetic acid 50% Glycolic acid: 1-2ml depending upon the area of involvement Topical application 1-2minutes contact duration Frequency one time application for 4-5 sittings

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Acanthosis nigricans between 18 to 25years giving consent for procedure. 2.Both gender are included

Exclusion criteria

Exclusion criteria: 1.pregnant female 2.patients with recurrent herpes infection,hypertrophic scars,keloid,active dermatitis 3.patients not willing for study. 4.patient less than 18years and more than 55years.

Design outcomes

Primary

Measure	Time frame
To asses the clinical outcome of 35% Trichloroacetic acid and 50% Glycolic acid peel in Acanthosis nigricans.Timepoint: Clinical outcome assesed after 5 sittings of application	—

Secondary

Measure	Time frame
To asses the tolerability and side effects of 35% Trichloroacetic acid and 50% Glycolic acid peel in Acanthosis nigricansTimepoint: Tolerability and side effects assesed every session of topical application.	—

Countries

India

Contacts

Public ContactDrJhanaranjane M

aarupadai medical college and research institute

oudeacoumar.paquirissamy@avmc.edu.in9443534341

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026